**Core Concept**
The patient presents with gynecomastia (breast enlargement in males) and a testicular mass, along with low serum levels of luteinizing hormone (LH) and testosterone. This clinical presentation suggests a disorder of testicular function, possibly related to a tumor affecting the Leydig cells or Sertoli cells.

**Why the Correct Answer is Right**
The combination of gynecomastia and low testosterone levels in the presence of a testicular mass is highly suggestive of a Sertoli cell tumor, also known as a Sertoli-Leydig cell tumor. Sertoli cells are responsible for the production of inhibin, which inhibits the secretion of follicle-stimulating hormone (FSH) from the pituitary gland. Low inhibin levels can lead to increased FSH secretion, which in turn stimulates the growth of breast tissue, resulting in gynecomastia. The low testosterone levels are due to the tumor's effect on Leydig cell function.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not directly related to the clinical presentation. While Klinefelter syndrome is a genetic condition that affects males and can lead to gynecomastia, it is not the most likely cause in this scenario given the presence of a testicular mass.

**Option B:** This option is incorrect because Leydig cell tumors typically present with virilization (e.g., acne, hirsutism) due to excess testosterone production, not gynecomastia.

**Option C:** This option is incorrect because primary hypogonadism (e.g., Klinefelter syndrome) would typically present with elevated FSH and LH levels, not low levels.

**Option D:** This option is not directly related to the clinical presentation. While testicular trauma can lead to testicular atrophy and gynecomastia, it is not the most likely cause in this scenario given the presence of a testicular mass.

**Clinical Pearl / High-Yield Fact**
The presence of a testicular mass in a male patient with gynecomastia and low testosterone levels should raise suspicion for a Sertoli cell tumor. Inhibin levels can be used to differentiate Sertoli cell tumors from Leydig cell tumors.

**Correct Answer: C.**